Rachel Smith, Ph.D., is collaborating with researchers across UAB on the two-year project, which will focus on the ...

Investigators continue to gather information and we will release further updates ... The school shared a photo and said she was preparing for her pinning ceremony in January.Gillespie also worked as a ...

Robotic-assisted HoLEP (RoLEP™) represents the first clinical application of its platform ... Gilling, and are thrilled with ...

In obesity hypoventilation syndrome (OHS), a patient’s gender is not independently linked to worse clinical outcomes after adjusting for age.

Vivani Medical, Inc. (Nasdaq: VANI) ("Vivani" or the "Company"), an innovative biopharmaceutical company developing novel, ...

Ricardo Bermúdez, a neurosurgeon and investigator at The Panama Clinic. "The technology's minimally-invasive surgical approach and ability to be inserted anywhere in the brain enables physicians like ...

A machine learning tool incorporating both clinical and genomic data helps predict response to CDK4/6 inhibitor therapy in ...

The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.

New York, New York--(Newsfile Corp. - December 19, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BioAge Labs, Inc. (NASDAQ: BIOA) for potential ...

The team at Monash Institute of Pharmaceutical Sciences in Australia believe they may have solved the issue that has caused ...

The findings from the CBL-0204 Phase 2b clinical trial have been selected for presentation at IMCAS, the premier global congress in aesthetic medicine. The data will be highlighted in both the 2025 ...

Special Report: BlinkLab has announced a positive outcome from a pre-submission meeting with the US Food and Drug Administration (FDA) to support the registration of its Dx 1 platform as an aid in the ...